| Literature DB >> 24669940 |
Shih-Chieh Yang, Tsai-Sheng Fu, Hung-Shu Chen1, Yu-Hsien Kao, Shang-Won Yu, Yuan-Kun Tu.
Abstract
BACKGROUND: Spinal infections remain a challenge for clinicians because of their variable presentation and complicated course. Common management approaches include conservative administration of antibiotics or aggressive surgical debridement. The purpose of this study was to evaluate the efficacy of percutaneous endoscopic debridement with dilute betadine solution irrigation (PEDI) for treating patients with lumbar infectious spondylitis.Entities:
Mesh:
Substances:
Year: 2014 PMID: 24669940 PMCID: PMC3986884 DOI: 10.1186/1471-2474-15-105
Source DB: PubMed Journal: BMC Musculoskelet Disord ISSN: 1471-2474 Impact factor: 2.362
Figure 1Intraoperative endoscopic views from the inside of L5-S1 infectious spondylitis. At the beginning of the PEDI procedure, the endoscopic view was not clear due to pus accumulation and granulation tissue at the infected disc level (A). Discectomy forcep, flexible rongeur, and shaver were then inserted through the cannulated sleeve to withdraw as much infected tissue as possible (B). By aggressive percutaneous debridement, the endoscopic view became much clear and the vertebral endplate above the infected disc level could be identified (C).
Figure 2PEDI procedure. Two portal working sheaths were used for percutaneous endoscopic debridement followed by dilute betadine solution irrigation (PEDI) for treating patients with lumbar infectious spondylitis (A). A negative-pressure Hemovac with 2 drainage tubes was inserted through the sheaths for further continuous drainage of the offending pathogens (B). Informed consent was obtained from the patient for his image to be published in this study.
Patients’ demographic data and clinical outcomes
| 1 | L2-3 single-level infection | Good | OSSA | None | None |
| 2 | L3-4 postoperative infection | Good | ORSA | None | None |
| 3 | L2-3 single-level infection | Good | No growth | None | None |
| 4 | L2-3 single-level infection | Good | ORSA | 2 months later | None |
| 5 | L3-4 infection with paraspinal abscess | Good | Pseudomonas aeruginosa | None | None |
| 6 | L5-S1 single-level infection | Good | Prevotella | None | None |
| 7 | L5-S1 infection with epidural abscess | Good | Streptococcus viridans | None | None |
| 8 | L3-4, L4-5, and L5-S1 multilevel infection | Poor | Mycobacterium tuberculosis | 1 week later | Paresthesia |
| 9 | L4-5 and L5-S1 multilevel infection | Good | ORSA | None | None |
| 10 | L2-3 single-level infection | Good | ORSA, Haemophilus influenzae | None | None |
| 11 | L4-5 single-level infection | Good | OSSA | None | None |
| 12 | L1-2 single-level infection | Good | Enterococcus faecalis | None | None |
| 13 | L3-4 and L4-5 multilevel infection | Fair | Pseudomonas aeruginosa | 2 weeks later | Paresthesia |
| 14 | L2-3 infection with paraspinal abscess | Good | OSSA | None | None |
| 15 | L4-5 postoperative infection | Good | Streptococcus viridans | None | None |
| 16 | L2-3 single-level infection | Good | Haemophilus influenzae | None | None |
| 17 | L4-5 single-level infection | Excellent | OSSA | None | None |
| 18 | L5-S1 infection with epidural abscess | Good | ORSA | None | None |
| 19 | L3-4 postoperative infection | Good | OSSA | None | None |
| 20 | L2-3 single-level infection | Fair | No growth | 1 week later | None |
| 21 | L5-S1 postoperative infection | Good | OSSA | None | None |
| 22 | L5-S1 single-level infection | Good | No growth | None | None |
| 23 | L4-5 single-level infection | Fair | No growth | None | None |
| 24 | L4-5 infection with epidural abscess | Good | OSSA, Escherichia coli | None | None |
| 25 | L3-4 and L4-5 multilevel infection | Fair | Haemophilus influenza | 2 weeks later | Paresthesia |
| 26 | L5-S1 infection with presacral abscess | Good | ORSA | None | None |
| 27 | L4-5 single-level infection | Good | klebsiella pneumoniae | None | None |
| 28 | L4-5 single-level infection | Good | Candida albicans | None | None |
| 29 | L3-4 infection with paraspinal abscess | Good | OSSA | 5 months later | None |
| 30 | L2-3 infection with paraspinal abscess | Excellent | ORSA | None | None |
| 31 | L4-5 postoperative infection | Good | ORSA | None | None |
| 32 | L4-5 single-level infection | Good | OSSA | None | None |
M = male, F = female, L = lumbar spine, S = sacral spine, OSSA = oxacillin sensitive staphylococcus aureus, ORSA = oxacillin resistant staphylococcus aureus.
*Evaluation at one week after PEDI.
Figure 3Epidural abscess treated by PEDI. L4-5 infectious spondylitis was diagnosed in a male patient. Sagittal T1- and T2-weighted and contrast magnetic resonance imaging (MRI) showed L4-5 epidural abscess with compression of neural elements (A). After PEDI treatment, sagittal T2-weighted MRI at 6 months follow-up demonstrated the disappearance of the abscess (B). Lateral computed tomograph revealed L4-5 disc space narrowing leading to spontaneous fusion (C).
Figure 4Presacral abscess treated by PEDI. L5-S1 infectious spondylitis was diagnosed in a male patient. The lateral radiograph showed L5 inferior endplate erosion (A). Sagittal T2-weighted MRI demonstrated presacral abscess (B). Postoperative sagittal T2-weighted MRI revealed the abscess was eradicated by PEDI (C). Postoperative lateral radiograph showed L5-S1 disc space collapse leading to spontaneous fusion (D).
Highest preoperative Erythrocyte Sedimentation Rate (ESR), C-reactive Protein (CRP), and White Blood Cell (WBC) count, and time to return to normal value in 26 patients successfully treated by percutaneous endoscopic debridement with dilute betadine solution irrigation
| 1 | 83 | 3 | 112 | 4 | 8960 | Initial WNL |
| 2 | 18 | 4 | 25 | 3 | 7670 | Initial WNL |
| 3 | 120 | 3 | 102 | 5 | 9990 | Initial WNL |
| 4 | 55 | 2 | 31 | 2 | 11030 | 3 |
| 5 | 50 | 5 | 78 | 4 | 7520 | Initial WNL |
| 6 | 55 | 3 | 46 | 4 | 8630 | Initial WNL |
| 7 | 34 | 4 | 22 | 2 | 8660 | Initial WNL |
| 8 | 34 | 1 | 138 | 4 | 12370 | 3 |
| 9 | 86 | 5 | 104 | 6 | 9640 | Initial WNL |
| 10 | 33 | 4 | 38 | 4 | 6920 | Initial WNL |
| 11 | 52 | 4 | 103 | 3 | 10140 | Initial WNL |
| 12 | 55 | 3 | 46 | 3 | 16140 | 4 |
| 13 | 131 | 6 | 35 | 4 | 12370 | 3 |
| 14 | 49 | 4 | 38 | 2 | 5780 | Initial WNL |
| 15 | 60 | 4 | 93 | 6 | 4630 | Initial WNL |
| 16 | 111 | 4 | 104 | 6 | 16490 | 5 |
| 17 | 104 | 5 | 182 | 6 | 21620 | 5 |
| 18 | 34 | 3 | 18 | 2 | 9190 | Initial WNL |
| 19 | 37 | 5 | 177 | 6 | 7820 | Initial WNL |
| 20 | 58 | 3 | 64 | 2 | 11130 | 2 |
| 21 | 39 | 2 | 58 | 6 | 11770 | 3 |
| 22 | 67 | 1 | 93 | 3 | 3590 | Initial WNL |
| 23 | 123 | 1 | 377 | 6 | 14990 | 4 |
| 24 | 62 | 2 | 92 | 6 | 6590 | Initial WNL |
| 25 | 37 | 3 | 52 | 6 | 8750 | Initial WNL |
| 26 | 62 | 4 | 89 | 5 | 12690 | 3 |
| Mean | 63.4 | 3.4 | 89.1 | 4.2 | 10195 | 3.5 |
Preop = preoperative, WNL = within normal limit.
Figure 5ESR and CRP changed by PEDI. Percentage changes in serological values, before and after PEDI, in successfully treated patients.